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Abstract 
Background 
Although measles mortality has declined dramatically in Sub-Saharan Africa, measles 
remains a major public health problem in countries like the Democratic Republic of Congo 
(DRC). Here, we describe the large measles epidemic that occurred in the Democratic 
Republic of Congo between 2010 and 2013 using data from the national surveillance system 
as well as vaccine coverage surveys to provide a snapshot of the epidemiology of measles in 
DRC. 
Methods 
Standardized national surveillance data were used to describe measles cases from 2010 to 
2013. Attack rates and case fatality ratios were calculated and the temporal and spatial 
evolution of the epidemic described. Data on laboratory confirmation and vaccination 
coverage surveys as a part of routine program monitoring are also presented. 
Findings 
Between week 1 of 2010 and week 45 of 2013, a total of 294,455 cases and 5,045 deaths 
were reported. The cumulative attack rate (AR) was 0.4%. The Case Fatality Ratio (CFR) 
was 1.7% among cases reported in health structures through national surveillance. A total of 
186,178 cases (63%) were under 5 years old, representing an estimated AR of 1.4% in this 
age group. Following the first mass vaccination campaigns, weekly reported cases decreased 
by 21.5%. Results of post-vaccination campaign coverage surveys indicated sub-optimal 
(under 95%) vaccination coverage among children surveyed. 
Conclusions 
The data reported here highlight the need to seek additional means to reinforce routine 
immunization as well as ensure the timely implementation of Supplementary Immunization 
Activities to prevent large and repeated measles epidemics in DRC. Although reactive 
campaigns were conducted in response to the epidemic, strategies to ensure that children are 
vaccinated in the routine system remains the foundation of measles control. 
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Background 
Globally, a disproportionate number of measles cases and deaths occur in low-income 
countries with weak health infrastructures [1]. In Sub-Saharan Africa, many countries have 
not yet introduced a second dose of measles-containing vaccine (MCV) into routine 
immunization programs. For children in these countries, the current World Health 
Organization (WHO) and United Nations Children’s Fund (UNICEF) strategy is to deliver 
the first dose of MCV during routine vaccination programs and the second through regular 
supplementary immunization activities (SIAs). This strategy reduces the burden of measles 
[2] and in recent years mortality due to measles has dramatically declined [3]. However, 
despite the availability of an effective, safe and affordable vaccine [4] and progress in 
controlling the disease, there were still an estimated 158,000 measles related-deaths in 2011 
[5]. 
The Democratic Republic of Congo (DRC) established the Expanded Program on 
Immunization (EPI) in 1978. A good barometer for EPI program performance is third-dose 
vaccination coverage for the Diphtheria-Tetanus-Pertussis vaccine (DTP), which calls for 
doses at 6, 10 and 14 weeks. Results from the 2007 Demographic Health Survey (DHS) show 
DTP3 coverage in DRC to be only 45% and the DTP1‐3 drop‐out rate to be 36%, one of the 
highest rates in the world [6]. More recent results from the Multiple Indicator Cluster Survey 
(MICS) showed an increase to 61% in country-wide DTP3 coverage although at province 
level estimates ranged from 27% registered in Maniema to 87% registered in Bandundu 
Province [7]. 
Between 2000 and 2010, first-dose MCV coverage for infants 9–11 months of age increased 
from 46% to over 70% [8]. Supplementary immunization activities for children 6–59 months 
were planned at three year intervals to provide either a second dose of measles vaccine or a 
second opportunity for vaccination to children not receiving their first dose through the 
routine program. Large measles SIAs were carried out between 2002 and 2004, and then 
again in 2006–2007. During these campaigns, a total of 30.2 million children were 
vaccinated. Nonetheless, vaccine coverage remains below the target threshold of 95% (Figure 
1). The vast size of the country, its poor infrastructure and transport network, and the 
weakness of its health system in difficult-to-access areas have resulted in difficulties in 
improving both routine vaccination and in the implementation of SIAs. 
Figure 1 Evolution of coverage and number of suspected and confirmed measles cases 
reported from 2002 to 2010, Democratic Republic of Congo. The bars represent the 
number of cases reported and the line represents the measles vaccination coverage. 
The medical humanitarian organization Médecins Sans Frontières (MSF), present in DRC 
since 1981, has been an important partner of the Ministry of Health (MOH) in responding to 
measles epidemics during the past decade. Standard epidemic responses include reinforcing 
measles surveillance in affected areas, providing free care to reduce measles mortality, and 
reactive vaccination campaigns in order to stop measles transmission during epidemics. In 
recent years, MSF has collaborated with the central MOH to improve measles surveillance 
activities across the country and carried out multiple outbreak response vaccination 
campaigns. Over the past ten years, measles outbreaks have been reported in several 
Provinces (Kinshasa, Bas Congo, Maniema, Kasai Oriental) with many reported after 
significant delay according to Ministry of Health [7]. From 2005 to 2008 the genotype B2 has 
been identified and circulating in DRC [9]. 
The current large measles epidemic began in DRC in October 2010. Five provinces (Katanga, 
Kasaï Oriental, Kasaï Occidental, Sud Kivu, Maniema) were primarily involved, but 
Equateur and Oriental provinces were also affected [10]. In each of these provinces, SIAs 
campaigns were scheduled for 2010 but had not yet been conducted when the epidemic 
started. Financial and logistic reasons were at the origin of this delay, which undoubtedly 
contributed to increasing the pool of susceptible individuals. Here we present national 
surveillance data from 2010–2013, the period coinciding with this major measles epidemic. 
Methods 
Measles cases in DRC are routinely reported through the integrated disease surveillance 
(IDS) system, which aims to strengthen surveillance capacity, to better identify disease 
prevention priorities and to provide epidemiological information for disease control. The IDS 
functions at several different levels. At the lowest level, information on measles and other 
reportable diseases is collected on a weekly basis in Health Areas. Information then passes 
upwards through Health Zones (HZ), Health Districts (HD), and provincial-level ministries of 
health, which are responsible for transmitting data to the central-level MOH in Kinshasa. An 
HZ has a variable catchment area, with populations ranging from 26,547 inhabitants in Kowe, 
Katanga Province, to an estimated 284,187 inhabitants in Ibanda, South Kivu Province. 
Following WHO guidelines, in DRC, a suspected measles case is defined as fever >38 ºC and 
rash, with at least one of the following: cough, coryza or conjunctivitis. A confirmed measles 
case is a suspected case with positive IgM antibodies for measles, or a suspected case 
occurring during an already-confirmed outbreak. A measles death is defined as death from an 
illness that occurs in a confirmed case of measles within one month of the onset of a rash. All 
data on cases and deaths were collected on a standard case report form and were routinely 
transmitted through the IDS system. In the current epidemic, blood specimens of early 
suspected cases in each HZ (between 5 and 10) were collected and laboratory confirmed by 
the National Institute of Biomedical Research (INRB) in Kinshasa, where measles and 
rubella IgM ELISA are performed. 
Epidemic definitions are also standardized: a suspected measles epidemic is defined as five or 
more suspected cases of measles in one HZ within one month and a confirmed measles 
epidemic is defined as at least three laboratory-confirmed measles cases in a HZ within one 
month. An epidemic alert was defined as 1 or 2 laboratory-confirmed measles cases in one 
HZ, or as a HZ without a recent vaccination campaign that neighbored a HZ already in 
epidemic. Of note, once an epidemic has been declared in an area, serological confirmation is 
not continued. In the presence of a laboratory-confirmed epidemic, all suspected cases based 
on clinical criteria are considered confirmed cases. 
WHO regional guidelines recommend case-based surveillance for measles [11], but this 
practice is not yet universal in DRC. Only a limited number of cases were registered with age 
and vaccination status as aggregate data is presented on the IDS form. Available information 
included numbers of suspect and confirmed cases by age group, as well as reported mortality. 
This was collected from the Epidemiologic Surveillance Division of the MOH in Kinshasa. 
In addition to surveillance data, we also present information on estimated vaccination 
coverage from routine monitoring surveys conducted post-vaccination campaign. Between 
2010 and 2013, MSF conducted multiple household-based surveys in different areas of DRC, 
providing local information on vaccination coverage. Results of these surveys and their 
respective methodologies are reported elsewhere [12,13]. 
As IDS data is not routinely digitized, data entry was performed in Microsoft Excel. We 
calculated attack rate (AR), expressed as measles cases divided by the population at risk, and 
case fatality ratio (CFR), defined as measles deaths divided by the clinically confirmed and 
suspected measles cases. For the former, the population at risk is a projection based on 
implied growth rates applied to the 1984 census, the DRC’s most recent. 
Ethical considerations 
This descriptive analysis used routine surveillance data collected by the MOH and MSF. Data 
were not nominative, and authorization for using the data was obtained from the MOH. This 
data was exempt from review by the MSF Ethical Review Board (ERB) and the national ERB 
in Kinshasa as routinely collected data were used. During vaccine coverage surveys, verbal 
informed consent was obtained from each head of household visited [12]. Privacy and 
confidentiality of patients were ensured by ensuring that no identifying information was 
recorded. 
Findings 
In April 2010, Kabalo HZ of Katanga Province reported an increase in suspected measles 
cases. By week 36–2010, two additional HZ (Sakania and Dilolo) reported an increased 
number of cases. The first samples were confirmed as being measles IgM-positive by ELISA 
at the INRB during week 38–2010. Since then, measles cases continued to be reported in 
every province of the country. MSF, in collaboration with the MoH, implemented vaccination 
campaigns in Sakania and Dilolo during weeks 41 and week 48–2010, respectively. 
Numbers of reported measles cases by week on a national level between weeks 1–2010 and 
45–2013 are presented in Figure 2. During 2011, we note two large peaks, due mostly to 
cases reported in the Katanga and Kasaï Oriental provinces. During these peaks, over 5,000 
measles cases were reported each week. Cases decreased slightly from 5033 to 3920 per 
week following the first mass vaccination campaigns in weeks 17 and 18–2011 which took 
place in part of Kasaï Oriental, part of Kasaï Occidental, part of Katanga, in Maniema and in 
Sud Kivu, then decreased sharply (69%) by week 33–2011 following a second mass 
vaccination campaign which was extended to the remaining health zones of Kasaï Oriental, 
Kasaï Occidental and Katanga. The number of reported cases then remained relatively low 
through early 2012. By the second half of 2012, reported cases began to rise again, this time 
driven by cases reported in Equateur and Orientale provinces. This uneven geographic 
distribution of cases is seen in Figure 3, which presents measles data by individual HZ – 
showing the HZ post-epidemic, in epidemic phase, or on epidemic alert. Two weeks, 
representative of the peaks of 2011 and 2013, are shown. 
Figure 2 Number of suspected and confirmed measles cases reported by week, 
Democratic Republic of Congo, week 1–2010 to week 45–2013. During this period reactive 
vaccination campaigns were carried out by Médecins Sans Frontières (MSF) and Ministry of 
Health (MoH) in collaboration with WHO Afro and Unicef. Black arrows and brackets 
indicate campaigns conducted by MSF and the MoH. Gray arrows and brackets indicate the 
campaigns conducted by WHO and Unicef in collaboration with MoH. Brackets indicate that 
the campaigns were carried out over several weeks. 
Figure 3 Health Zones in epidemic and on alert for measles, Democratic Republic of 
Congo, week 34–2011 and week 14–2013. We present two points in time to represent the 
spatial and temporal evolution of the epidemic. White areas represent health zones (HZ) not 
in epidemic, yellow areas represent the HZs at risk of epidemic, the red areas represent the 
HZs in epidemic and the green areas the HZs in post epidemic. In the first map, cross-hatched 
HZ had been vaccinated between October 2010 and August 2011, in the second, cross-
hatched HZ had been vaccinated between January 2012 and April 2013. 
Nationwide numbers of reported cases and measles-related deaths by year for the period 
between weeks 1–2010 and 45–2013 are presented in Table 1. A total of 294,455 cases were 
reported during this period, over 70% of which occurred in children under 5 years of age. 
5,045 measles-related deaths were reported over the same period, representing an overall 
reported CFR of 1.7%. There was significant yearly variation in the reported CFR, ranging 
from 1.2% in 2011 to 2.7% in 2012. A total of 2946 cases were laboratory-confirmed 
between July 2010 and December 2012. A large proportion (29%) of confirmed cases aged 
between 9 months and 4 years reported never having received a measles vaccination, and 
\37% of confirmed cases had no available information about prior vaccination status. 
  
Table 1 Suspected and confirmed measles cases and deaths reported by year, 
Democratic Republic of Congo, 2010-2013 
Year Total cases Cases <5 years old, n (% of total cases) Deaths CFR†† 
2010 4 861 2 615 (74.4) 79 1.6% 
2011 133 801 101 142 (75.6) 1 646 1.2% 
2012 73 844 51 606 (69.9) 2 023 2.7% 
2013* 81 949 29 815 (−−)† 1 297 1.6% 
Total 294 455 186 178 (63) 5 045 1.7% 
*Only from week 1 to week 45. 
† This percentage is not calculated as the number of cases aged <5 was not reported between weeks 1 and 12–2013. 
††CFR: Case Fatality Ratio is the proportion of measles deaths divided by the clinically confirmed cases within a given 
period time. 
The overall cumulative AR for this epidemic was 0.4%, and 1.4% among children under 5 
years. Cumulative AR by province is shown in Table 2. This information is also presented in 
Figure 4, which combines province-level attack rates with province-level epidemic curves. 
Table 2 Cumulative measles attack rates by province, Democratic Republic of Congo, 
2010-2013 
Provinces Total population* Measles cases 2010-2013 AR% 
Bandundu 7 714 915 13 136 0.17% 
Bas Congo 3 334 201 2 143 0.06% 
Equateur 8 629 816 34 172 0.40% 
Kasaï Occidental 7 216 209 16 595 0.23% 
Kasaï Oriental 9 136 786 47 899 0.52% 
Katanga 9 707 496 94 181 0.97% 
Kinshasa 7 092 711 2 531 0.04% 
Maniema 2 009 182 12 312 0.61% 
Nord Kivu 6 347 169 2 229 0.04% 
Orientale 9 487 106 63 272 0.67% 
Sud Kivu 4 864 044 5 985 0.12% 
Total 75 539 635 294 455 0.39% 
* Average projected population over the period 2010-2013. 
Figure 4 Measles cumulative attack rate (ARs) per 100 000 inhabitants by province, 
Democratic Republic of Congo, week 1–2010 through 43–2013. ARs are presented in gray 
scale on the map (darker represents higher AR). Weekly incidence is presented for the most 
affected provinces (x-axis represents epidemiologic week by year, y-axis represents number 
of incident cases reported). 
During this period, reactive vaccination campaigns were carried out in 190 out of 516 HZ and 
SIAs were organized in 378 HZ (some HZ received reactive campaigns later followed by 
SIAs). Most targeted children aged 6 months – 15 years, others targeted children aged 6 
months – 10 years and others 6 months – 5 years. 
Results from vaccine coverage surveys carried out by MSF are presented in Table 3. All of 
these surveys took place in areas where reactive vaccination campaigns occurred, thus all 
were in HZs with measles epidemics. It is important to note the great variation in pre-
campaign coverage, a surrogate marker for prior vaccination opportunities, e.g. EPI, SIAs. 
  
Table 3 Results of routine vaccine coverage surveys, DRC, 2011–20131 
Province Health district EPI VC before mass campaign VC after mass campaign 
  By card and oral By card and oral 
Kasaï Occidental Tshikapa 54.4% [43.5-65.3] 97% [94.8-99.3] 
Orientale Watsa 57.3% [50.4-64.1] 99.2% [98.5-100] 
Katanga Sakania 69.1% [58.7-79.5] 95.3% [92.3-98.4] 
Katanga Kasenga 86.2% [80.5-90.4] 93.7% [91–95.7] 
Katanga Kapolowe 83.1% [74–89.4] 97% [88–99.3] 
Kasaï Oriental Mwene Ditu 70.5% [63.1-77.8] 98.8% [97.6-100] 
Equateur Yambuku 39.70% [28.2-51.4] 95.4% [92.1-98.6] 
Orientale Yaleko 39% [31.2-47.3] 97.6% [96.4-99.9] 
Orientale Yalimbongo 34.4% [23.1-47.4] 98.2% [96.5-99.9] 
Orientale Yahuma 44% [36–52] 95% [93–98] 
Orientale Yahisuli 49% [39–58] 97% [95–99] 
1Data from Katanga Province were first published in Grout L, Minetti A, Hurtado N, François G, Fermon F, Chatelain A, 
Harczi G, Ilunga Ngoie J, N’Goran A, Luquero J F, Grais R F, Porten K: Measles in Democratic Republic of Congo : an 
outbreak description from Katanga, 2010–2011. BMC Infectious Diseases, 2013. 13 (1): p.232. 
The results of household-based surveys in specific HZ during this period show pre-outbreak 
response vaccination coverage to be heterogeneous (Table 3). In some HZ, the post-campaign 
coverage increased up to 98%. This variability is corroborated by the 2007 Demographic 
Health Survey, which showed varying levels of coverage between provinces. Maniema and 
Equateur had the lowest vaccination coverage (10% and 15% respectively), while Nord Kivu 
(67%), Bas Congo (60%) and Kinshasa (58%) had the highest rates. 
Discussion 
A lengthy measles epidemic has been occurring in DRC since 2010, and was still ongoing at 
the end of 2013. To interrupt endemic transmission of measles, mathematical models indicate 
that 93%-95% of a population must be immune [14], a distant threshold in DRC, where a lack 
of access to care, political instability, and poor physical infrastructure have led to low routine 
vaccination coverage and continuing measles endemicity. This endemicity is also reflected in 
the high proportion of cases seen among children under 5. Given that MCV coverage has 
been quite low for many years, it is likely that older children and adults have been protected 
against measles via naturally-acquired immunity after prior exposure to measles. 
This prolonged epidemic has spread across the country over a period of almost 3 years. The 
data presented at the level of HZs (Figure 3) show a slow progression of the epidemic across 
the country which confirms subjective impressions of the epidemic’s spread. Nonetheless, it 
is important to note that some HZ in the north were in epidemic phase in 2011, and that some 
HZ in the south were in epidemic phase in 2013, further illustrating measles endemicity 
throughout DRC. 
Considering the steep increase in measles cases in Eastern and Southern Africa between 2009 
and 2010, we cannot exclude the possibility that this epidemic might have resulted also from 
multiple introductions from neighboring countries. From 2005 to 2008, genotype B2 was 
identified as circulating in DRC [9], but molecular information from the epidemic in 2010–
2013 showed the circulation of both genotype B2 and B3, the same genotypes reported in 
recent epidemics in Angola and Zambia [14]. The HZ of Sakania, adjacent to Zambia, 
reported an increase in cases at the end of 2010, and the HZ of Dilolo (Katanga) and 
Kamonia (Kasai Occidental), both bordering Angola, reported increase in cases between 
weeks 36 and 46–2010. 
Nonetheless, several caveats about the data should be highlighted. 
First, the attack rates presented are calculated using population estimates based on the 1984 
census. For many reasons, these population estimates, based on an annual growth of 3%, are 
likely inaccurate. Use of population projections is a known weakness and in countries without 
accurate population data, and contributes to difficulties in assessing coverage. This is 
particularly evident when examining administrative vaccination coverage (number of doses 
administered divided by the presumed target population), where rates of over 100% are often 
reported [15]. However, they are the standard figures used in the DRC, and remain the most 
rational option until a new census is conducted. 
Secondly, the case fatality ratios should also be interpreted with caution. They were low 
compared with other African settings [16-19]. In the DRC, where access to care is limited, 
the low CFR is likely due to an underreporting of deaths, many of which happen outside of 
health structures. At the same time, measles cases may have been overestimated using the 
clinically confirmed case definition, as some provinces had concurrent rubella epidemics. 
Finally, the surveillance system in DRC is still a work in progress: line lists were not 
completed in most districts, and only aggregate age information was recorded. The 
completeness of data is weak, and the sensitivity of the surveillance system has not been 
formally evaluated [14]. 
In summary, in a country the size of Western Europe, case reporting for measles and many 
other diseases is incomplete, varying greatly by province. Therefore epidemiological analysis 
did not fully represent all measles cases in the country. 
Despite the variation in baseline MCV coverage, it is important to note that all of the areas 
experiencing epidemics had a pre-epidemic MCV coverage below 95%. The end result is an 
epidemic that has caused almost 300,000 cases and over 5,000 deaths. The heterogeneity of 
the epidemic is consistent with the heterogeneity of vaccine coverage in the country. The 
Demographic Health Survey of 2007 estimated nationwide MCV1 coverage at 63%, but 
vaccination coverage varied greatly among the provinces. Katanga and Oriental provinces 
(both greatly affected in the current epidemic) had a coverage respectively of 51% and 49%. 
In contrast, the highest levels of vaccination coverage were in North Kivu (85%), Bas Congo 
(88%) and Kinshasa (91%), the least-affected provinces in this epidemic. In 2012, a 
vaccination coverage survey conducted by the Public Health University of Kinshasa, 
confirmed a similar situation [20]. 
WHO guidelines for outbreak response in measles mortality reduction settings like the DRC 
recommend non-selective vaccination campaigns to control epidemics [11]. Nonetheless, in a 
country the size of the DRC with its problems of inaccessibility, the sheer logistical burden 
presented by the prospect of carrying out many campaigns at the same time is daunting. 
Many of the reactive vaccination campaigns conducted during this epidemic were carried out 
relatively late in the course of the epidemic in the given areas. This likely had a positive 
impact on the epidemic curve [21], but the impact would likely have been greater with an 
earlier response [22,23]. Some of the campaigns were conducted in some of the most affected 
districts but not always in neighboring districts where the epidemic could have spread. This 
leads further credence to the importance of context-specific approaches when planning mass 
vaccination responses to epidemics [24]. 
In health zones where MSF was implementing the reactive campaigns, the health surveillance 
system was strengthened with additional data collection, retrospective review of health 
registers and monitoring of data completeness. This more complete data revealed that cases 
were concentrated in children under 5 years old and the AR was lower for children older than 
10 years – a finding that led to the decision to vaccinate children between 6 months and 10 
years old in some settings. This approach could be applied in future responses to ensure the 
appropriate targeting of children, especially in difficult to reach areas with limited resources 
[25]. 
Ensuring a first dose in the routine program, followed by regular SIAs every two or three 
years, is the most efficient, and surely the most cost-effective way to increase measles 
vaccine coverage [26-29]. In the meantime, case-based measles surveillance should be 
strengthened and prompt outbreak investigations should be used to complement vaccination 
coverage information to identify gaps in population immunity. 
Conclusions 
Measles vaccination coverage in the DRC has improved in recent years but is still far below 
protective levels, leading to this large epidemic which affected mainly children under 5 years 
old. Reactive vaccination campaigns have been an important part of the response to this 
epidemic and have helped to increase vaccination coverage to desirable levels but they cannot 
be considered a sustainable measles control strategy over the long-term. Achieving a high 
coverage through a reinforcement of the routine immunization program and effective SIAs is 
the best way to prevent measles epidemics from occurring. Routine vaccination activities, as 
well as the nascent surveillance system, must be strengthened with a special focus on the 
case-based system. Detailed outbreak investigations and collection of additional data 
(compilation of line-lists) are recommended to describe the epidemiology and the age 
distribution of the epidemic, to guide rapid and effective reactive immunization campaigns 
and to target the most appropriate age groups. Population-based coverage surveys should be 
implemented after SIA activities to determine the susceptibility profile of the population and 
to identify areas of low coverage to better prioritize and efficiently use of resources. 
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